Clinical Trial Update: One Versus Twice Daily Administration of Multiple Cardiovascular Agents in Patients With Ischemic Heart Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on once versus twice daily administration of multiple cardiovascular agents in ischemic heart disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic Heart Disease

Snippet

Sponsor: University of Roma La Sapienza | Conditions: Ischemic Heart Disease | Phase 4 | Status: UNKNOWN